The Effect of Mouse Strain on Herpes Simplex Virus Type 1 (HSV-1) Infection of the Central Nervous System (CNS)
Overview
Affiliations
Background: Mice infected with HSV-1 can develop lethal encephalitis or virus induced CNS demyelination. Multiple factors affect outcome including route of infection, virus and mouse strain. When infected with a sub-lethal dose of HSV-1 strain 2 via the oral mucosa, susceptible SJL/J, A/J, and PL/J mice develop demyelinating lesions throughout the brain. In contrast, lesions are restricted to the brainstem (BST) in moderately resistant BALB/c mice and are absent in resistant BL/6 mice. The reasons for the strain differences are unknown.
Methods: In this study, we combine histology, immunohistochemistry, and in-situ hybridization to investigate the relationship between virus and the development of lesions during the early stage (< 24 days PI) of demyelination in different strains of mice.
Results: Initially, viral DNA and antigen positive cells appear sequentially in non-contiguous areas throughout the brains of BALB/c, SJL/J, A/J, and PL/J mice but are restricted to an area of the BST of BL/6 mice. In SJL/J, A/J, and PL/J mice, this is followed by the development of 'focal' areas of virus infected neuronal and non-neuronal cells throughout the brain. The 'focal' areas follow a hierarchical order and co-localize with developing demyelinating lesions. When antigen is cleared, viral DNA positive cells can remain in areas of demyelination; consistent with a latent infection. In contrast, 'focal' areas are restricted to the BST of BALB/c mice and do not occur in BL/6 mice.
Conclusions: The results of this study indicate that susceptible mouse strains, infected with HSV-1 via the oral mucosa, develop CNS demyelination during the first 24 days PI in several stages. These include: the initial spread of virus and infection of cells in non-contiguous areas throughout the brain, the development of 'focal' areas of virus infected neuronal and non-neuronal cells, the co-localization of 'focal' areas with developing demyelinating lesions, and latent infection in a number of the lesions. In contrast, the limited demyelination that develops in BALB/c and the lack of demyelination in BL/6 mice correlates with the limited or lack of 'focal' areas of virus infected neuronal and non-neuronal cells in these two strains.
, Neurodegenerative Disorders and Autoimmune Diseases: What Is the Relationship between Them?.
De Francesco M Viruses. 2024; 16(1).
PMID: 38257833 PMC: 10818483. DOI: 10.3390/v16010133.
Boukhvalova M, Kastrukoff L, Blanco J Front Aging Neurosci. 2023; 15:1204852.
PMID: 37396655 PMC: 10310923. DOI: 10.3389/fnagi.2023.1204852.
Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection.
Guo X, An Y, Tan W, Ma L, Wang M, Li J Front Microbiol. 2023; 14:1201505.
PMID: 37342565 PMC: 10277505. DOI: 10.3389/fmicb.2023.1201505.
Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers.
Kang K, Bernstock J, Totsch S, Gary S, Rocco A, Nan L Clin Cancer Res. 2022; 28(24):5419-5430.
PMID: 36239623 PMC: 9771977. DOI: 10.1158/1078-0432.CCR-22-1382.
Yajima S, Sugawara K, Iwai M, Tanaka M, Seto Y, Todo T Mol Ther Oncolytics. 2021; 23:402-411.
PMID: 34853811 PMC: 8605086. DOI: 10.1016/j.omto.2021.10.012.